Northland Securities Reduces Earnings Estimates for Transcat

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at Northland Securities decreased their Q3 2027 earnings per share estimates for shares of Transcat in a research note issued on Wednesday, August 5th. Northland Securities analyst T. Jackson now forecasts that the scientific and technical instruments company will earn $0.20 per share for the quarter, down from their previous estimate of $0.38. Northland Securities currently has a “Market Perform” rating and a $95.00 target price on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.63 per share. Northland Securities also issued estimates for Transcat’s FY2028 earnings at $2.12 EPS, FY2029 earnings at $2.58 EPS and FY2030 earnings at $3.01 EPS.

Several other research firms have also weighed in on TRNS. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. Weiss Ratings upgraded shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, May 28th. Finally, Wall Street Zen upgraded shares of Transcat from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Transcat currently has an average rating of “Hold” and an average target price of $105.50.

Transcat Stock Performance

NASDAQ TRNS opened at $94.54 on Friday. The firm has a market capitalization of $884.89 million, a P/E ratio of 255.51 and a beta of 0.68. The company has a current ratio of 2.49, a quick ratio of 1.99 and a debt-to-equity ratio of 0.36. The firm’s fifty day moving average price is $89.42 and its two-hundred day moving average price is $79.52. Transcat has a 1 year low of $50.23 and a 1 year high of $95.22.

Transcat (NASDAQ:TRNS) last released its earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $92.95 million during the quarter, compared to analysts’ expectations of $86.55 million. Transcat had a net margin of 0.99% and a return on equity of 5.56%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Diamond Hill Capital Management LLC Investment Advisor acquired a new stake in Transcat during the second quarter worth approximately $4,285,000. Bank of New York Mellon Corp acquired a new position in shares of Transcat in the second quarter valued at approximately $2,742,000. Oppenheimer Asset Management Inc. bought a new position in shares of Transcat during the second quarter worth approximately $956,000. Central Pacific Bank Trust Division increased its stake in shares of Transcat by 45.0% during the second quarter. Central Pacific Bank Trust Division now owns 3,817 shares of the scientific and technical instruments company’s stock worth $354,000 after purchasing an additional 1,184 shares during the period. Finally, Bank of America Corp DE lifted its holdings in Transcat by 2.9% during the 1st quarter. Bank of America Corp DE now owns 29,342 shares of the scientific and technical instruments company’s stock worth $2,155,000 after purchasing an additional 838 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Key Transcat News

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat’s latest quarterly results exceeded expectations, with earnings of $0.51 per share versus the $0.38 consensus and revenue of $92.95 million versus $86.55 million expected. The Service segment remains the primary growth driver, and management is targeting high-single-digit organic Service growth as it expands its operational-excellence initiatives. Transcat’s Q2 CY2026: Strong sales
• Positive Sentiment: Shares remain above both their 50-day and 200-day moving averages, reflecting strong recent momentum following the earnings beat and improving demand for calibration and technical services.
• Neutral Sentiment: Northland Securities maintains a “Market Perform” rating and a $95 price target, which is close to the stock’s recent trading level. This suggests the firm sees limited near-term valuation upside despite the company’s longer-term growth opportunities. Northland Securities rating information
• Negative Sentiment: Northland downgraded Transcat from “Outperform” to “Market Perform,” citing a less favorable risk-reward profile after the stock’s advance. The $95 target implies only modest upside from the referenced trading level.
• Negative Sentiment: Northland reduced its EPS forecasts across the outlook: Q2 2027 to $0.41 from $0.45, Q4 2027 to $0.60 from $0.62, FY2027 to $1.71 from $1.86, and FY2031 to $3.53 from $3.88. The revisions indicate concern about growth or profitability, while recent coverage also highlights persistent margin pressure. TRNS Q2 deep dive: Service segment drives growth, margin pressures persist

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.